These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 12682914)

  • 21. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
    Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC
    J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
    Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N
    Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
    Nagashima M; Asano G; Yoshino S
    J Rheumatol; 2000 Oct; 27(10):2339-42. PubMed ID: 11036826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.
    Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE
    Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
    Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
    Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.
    Samaniego F; Young D; Grimes C; Prospero V; Christofidou-Solomidou M; DeLisser HM; Prakash O; Sahin AA; Wang S
    Cell Growth Differ; 2002 Aug; 13(8):387-95. PubMed ID: 12193477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
    Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
    J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basic fibroblast growth factor as a growth factor for SRV-2-infected simian retroperitoneal fibromatosis cells, an animal model for AIDS related Kaposi's sarcoma.
    Chung CH; Chiang J; Jiang CM; Chen YY; Huang CY; Chen PG; Chen YJ
    Neoplasma; 2001; 48(3):192-9. PubMed ID: 11583288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
    Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S
    J Immunol; 1997 Jun; 158(11):5518-26. PubMed ID: 9164976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
    Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T
    Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu.
    Dezube BJ
    Semin Oncol; 2000 Aug; 27(4):420-3. PubMed ID: 10950368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk.
    Cassoni P; Sapino A; Deaglio S; Bussolati B; Volante M; Munaron L; Albini A; Torrisi A; Bussolati G
    Cancer Res; 2002 Apr; 62(8):2406-13. PubMed ID: 11956104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
    Feldman AL; Tamarkin L; Paciotti GF; Simpson BW; Linehan WM; Yang JC; Fogler WE; Turner EM; Alexander HR; Libutti SK
    Clin Cancer Res; 2000 Dec; 6(12):4628-34. PubMed ID: 11156212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
    Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
    FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
    Takahashi K; Saishin Y; Saishin Y; Silva RL; Oshima Y; Oshima S; Melia M; Paszkiet B; Zerby D; Kadan MJ; Liau G; Kaleko M; Connelly S; Luo T; Campochiaro PA
    FASEB J; 2003 May; 17(8):896-8. PubMed ID: 12670875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors.
    Miyashita M; Tajiri T; Yanagi K; Shimizu T; Futami R; Sasajima K; Tokunaga A
    Hepatogastroenterology; 2003; 50(50):308-9. PubMed ID: 12749209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis.
    Mallery SR; Bailer RT; Hohl CM; Ng-Bautista CL; Ness GM; Livingston BE; Hout BL; Stephens RE; Brierley GP
    J Cell Biochem; 1995 Nov; 59(3):317-28. PubMed ID: 8567750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.
    Dhanabal M; Ramchandran R; Volk R; Stillman IE; Lombardo M; Iruela-Arispe ML; Simons M; Sukhatme VP
    Cancer Res; 1999 Jan; 59(1):189-97. PubMed ID: 9892206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
    Dezube BJ; Sullivan R; Koon HB
    J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.